Respira Therapeutics
Albuquerque, US · Delaware corporation · 2 known investors
Founders & leadership
MF
Matthew FranklinExecutive
RM
Robert M. CurtisExecutive
AC
Andrew ClarkNamed on SEC filing
Board
DB
David BlivinBoard director
BP
Brian P. BirkBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$9.1M disclosed across 1 round · 2017
▶$9.1MraisedApr 2017 · 3 investors · PharmaceuticalsRule 506(b)
▶$9.1MraisedApr 2017 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David BlivinDirector
- Matthew FranklinExecutive Officer
- Andrew ClarkDirector
- Robert M. CurtisExecutive Officer, Director
- Brian P. BirkDirector
- Offering amount
- $9.4M
- Amount sold
- $9.1M
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Respira Therapeutics's investors?
- Respira Therapeutics's investors include Cottonwood Technology Fund, Samsara BioCapital.
- How much funding has Respira Therapeutics raised?
- Respira Therapeutics has disclosed $9.1M raised across 1 round.
- Where is Respira Therapeutics headquartered?
- Respira Therapeutics is headquartered in Albuquerque, US.